Oligonucleotides

ISIS116847 targets PTEN:
5'-C*T*G* C*T*A* G*C*C* T*C*T* G*G*A* T*T*T* G*A-3'; the underlined are 2'-O-MOE modified nucleotides and the * indicates phosphorothioate backbone. ISIS386652 is of the same sequence and chemistry as 116847, but is labeled at the 5' end with biotin. ISIS446654 is of the same sequence and chemistry as 116847, but is labeled at 5'end with Cy3. ISIS256903 is of the same sequence and chemistry as 116847, but is labeled at 5'end with FITC. XL180 is 5´-biotin-rArGrC rArGrU rUrCmU mCmAmA mAmUmC mCmAmG mAmGmG mCmUmA mGmCmA mG-3´, where r indicates ribo and m indicates 2'-Omethyl. XL180 is complementary to ISIS116847 and was used for affinity selection. XL181 was used for affinity selection and has the sequence 5´-biotin-rArGrC rArGrU rUrCmG mUmGmA mUmGmG mGmUmU mUmGmU mCmUmG mCmGmC mU-3´. XL279 is complementary to ASO116847 and has the sequence 5'-mUmCmA mAmAmU mCmCmA mGmAmG mGmCmU mAmGmC mAmG-3'.
ISIS110074 targets NCL1(ASO1):
5'-G*T*C* A*T*C* G*T*C* A*T*C* C*T*C* A*T*C* A*T-3'. ISIS110080 targets NCL1(ASO2): 5'-C*G*T* C*G*T* C*G*T* C*A*T* C*C*T* C*G*T* C*C-3'. ISIS395254 targets Malat1: 5'-G*G*C* A*T*A* T*G*C* A*G*A* T*A*A* T*G*T* T*C-3'. ISIS462026 targets U16: 5´-C*A*G* C*A*G* G*C*A* A*C*T* G*T*C* G*C*T* G*A-3´. ISIS25690 targets drosha: 5´-A*T*C* C*C*T* T*T*C* T*T*C* C*G*C* A*T*G* T*G-3´. ISIS286529 targets La: 5'-T*T*T* T*G*G* C*A*A* A*G*T* A*A*T* C*G*T* C*C-3'. ISIS573658 targets NPM1: 5'-T*A*A* A*G*T* G*A*T* A*A*T* C*T*T* T*G*T* C*G-3'.
Deoxynucleotides probes used for northern hybridization: XL057, 5'-CTCAGCCTCCCGAGTAGCTG-3', complementary to human 7SL RNA. XL030, 5'-TCCTTCGAGCCGGAATTGA-3', complementary to human tRNA 
Plasmids:
Plasmids for over-expression of La (EX-G0043-M02) and NPM1 (EX-Z2182-M02) were purchased from Genecopoeia. , as determined by northern hybridization. A polymerase II transcribed RNA, U16 snoRNA, was used as a control for loading. B) Reduction of NPM1 by siRNA treatment did not significantly affect the level of steady-state rRNAs as determined by gel electrophoresis and ethidium bromide staining. Levels of 7SL RNA from the same gel was determined by northern hybridization. C) Reduction of NPM1 did not significantly affect the subcellular distribution of RPL5 protein. Cytoplasmic and nuclear fractions were separated and the proteins were analyzed by western. hnRNP K and GAPDH served as nuclear and cytoplasmic markers, respectively, and ACTB was used as a loading control. (n=3), and the significance is indicated above the bars. "NS", not significant (P>0.05). "*", 0.01<P<0.05; "**", 0.001<p<0.01; "***", 0.0001<P<0.001; and "****", 0.00001<P<0.0001. E) Reduction of La, Ku70, or ANXA2 affected the ASO activity upon free uptake, as determined by qRT-PCR for the targeted NCL1 mRNA. P-values of the group difference were calculated based on two-tailed, paired t test, and is indicated beside the curves. The error bars indicate standard deviations of three independent experiments. Figure S9 . A) RNase H1 protein levels were not affected by treatment of cells with siRNAs targeting indicated genes as determined by western analysis. GRSF1 served as a loading control. B) Transfection of ASOs did not significantly affect the levels of RNase H1 or indicated ASO-binding proteins. HeLa cells were either mock transfected or transfected with 50 nM ASO116847; protein levels were detected by western analyses. C) La, NPM1, VARS, ANXA2, PC4, and Ku70/Ku80 proteins do not stably interact with RNase H1. Whole cell lysates prepared from Flag-H1 over-expressing cells were incubated with ASO116847 or ASO116847/XL279 duplex (20 nM/5 mg protein lysate/IP reaction) and subjected to immunoprecipitation using anti-Flag beads. The co-isolated proteins were eluted with Flag peptide and analyzed by western analysis. Figure S10 . A) Reduction of VARS altered lysosome patterns. The arrows indicate condensed lysosome structures. B) Reduction of VARS caused lysosome staining patterns to condense toward perinuclear structures in the absence of ASOs. HeLa cells were treated with two different siRNAs targeting VARS for 24 hrs and were stained for Lamp1. Scale bars: 10 μm. B) ANXA2 co-localized with ASOs in cytoplasmic loci upon transfection. HeLa cells were transfected with 50 nM ASO446654 for 8 hr and stained for ANXA2. The co-localization of aggregated ANXA2 and ASO is exemplified by arrows. Scale bars: 20 μm. C) ANXA2 and ASO co-localized in Lamp1-containing structures upon transfection. HeLa cells transfected for 8 hr with 50 nM ASO446654 were costained for ANXA2 and Lamp1. The co-localization of ANXA2, ASO, and Lamp1 is indicated with arrows. Scale bars: 10 μm. D) ANXA2 co-localized with ASOs 4 hr after ASO incubation, but not at 2 hr after ASO incubation. Scale bars: 20 μm for 2hr and 10 μm for 4 hr images. Figure S11 . ANXA2 was not enriched in early endosomes upon ASO incubation. HeLa cells were incubated with 2 μM ASO446654 for 24 hr, fixed, and co-stained for ANXA2 and EEA1 proteins. The localization of ASOs in some EEA1-stained early endosomes is exemplified by arrows. Scale bars: 10 μm. 
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